Synteract Announces Collaboration with iCAN Research


Applied Clinical Trials

Synteract, a CRO, has signed a memo of understanding to partner with the International Children’s Advisory Network (iCAN). iCAN and Synteract will come together to expand access to children and families worldwide in clinical research.

Read the full release here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.